DCF — HACKETTSTOWN MEDICAL CENTER
Enterprise Value: $10.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$10.9M
Enterprise Value
$0.1M
PV of Cash Flows
$10.8M
PV of Terminal Value
$17.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $123.2M | $4.0M | 3.0% | $-1.4M | $-1.3M |
| Year 2 | $126.9M | $5.4M | 4.0% | $-0.5M | $-0.4M |
| Year 3 | $130.7M | $6.9M | 5.0% | $0.5M | $0.3M |
| Year 4 | $134.6M | $7.8M | 6.0% | $1.0M | $0.7M |
| Year 5 | $138.6M | $8.4M | 6.0% | $1.3M | $0.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $10.9M. Terminal value accounts for 99% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$119.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.027821024977332187
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5